News from CEO:

President and CEO, Mr. Motoki Ozawa stated, The Food and Drug Administration has completed an evaluation of our firm’s corrective actions in response to its Warning Letter dated August 8, 2014. Based on their evaluation, the FDA confirmed that Nidek Inc. has addressed the issues contained in the Warning Letter and resulted in full resolution of this matter.

Nidek will continue to maintain compliance as well as the adequacy and sustainability of our activities.